YUNG H. CHYUNG

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by YUNG H. CHYUNG:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Chief Medical Officer Common Stock 258,496 $4,117,505 $15.93 14 Feb 2022 Direct
Keros Therapeutics, Inc. Chief Medical Officer Common Stock 44,000 $1,936,440 $44.01 18 Feb 2025 Direct
Tourmaline Bio, Inc. Chief Medical Officer Common Stock 56,836 $965,644 $16.99 19 Oct 2023 Direct
Keros Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 110,000 08 Nov 2024 Direct
Tourmaline Bio, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 73,211 23 Oct 2023 Direct
Scholar Rock Holding Corp Chief Medical Officer Stock Option (Right to Buy) 37,500 14 Feb 2022 Direct

Insider Reports Filed by YUNG H. CHYUNG

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 18 Feb 2025 1 $0 4 Chief Medical Officer 19 Feb 2025, 16:15
KROS Keros Therapeutics, Inc. 08 Nov 2024 1 $0 4 Chief Medical Officer 12 Nov 2024, 16:15
KROS Keros Therapeutics, Inc. 01 Nov 2024 0 $0 3 Chief Medical Officer 08 Nov 2024, 16:18
TALS Tourmaline Bio, Inc. 19 Oct 2023 3 $0 4 Chief Medical Officer 23 Oct 2023, 20:20
TALS Tourmaline Bio, Inc. 19 Oct 2023 0 $0 3 Chief Medical Officer 23 Oct 2023, 18:28
SRRK Scholar Rock Holding Corp 14 Feb 2022 2 $0 4 Chief Medical Officer 15 Feb 2022, 16:15
SRRK Scholar Rock Holding Corp 15 Jan 2022 1 -$27,657 4 Chief Medical Officer 19 Jan 2022, 18:01